Evidence map›Paper›PMID 33838723›Full record

ArticleLancet (London, England)2021

US-China health exchange and collaboration following COVID-19.

Liming Li, Kean Wang, Zhuo Chen, Jeffrey P Koplan

Abstract readHistorical ArticleComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Liming LiCenter for Public Health and Epidemic Preparedness and Response, Peking University, Beijing, China.
Kean WangThinkTank Research Center for Health Development, Beijing, China.
Zhuo ChenCollege of Public Health, The University of Georgia, Athens, GA, USA; Centre for Health Economics, School of Economics, University of Nottingham, Ningbo, China.
Jeffrey P KoplanEmory Global Health Institute, Emory University, Atlanta, GA, USA. Electronic address: jkoplan@emory.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strong US-China collaboration on health and medicine is a crucial element of the global effort against COVID-19. We review the history of health collaboration and exchanges between the public and private sectors in the USA and China, including the long-lasting collaboration between governmental public health agencies of the two countries. Academic and scientific exchanges should be reinvigorated and the increasing valuable role of non-profit foundations acknowledged. The shared interests of the two countries and the magnitude of the pandemic necessitate both countries to collaborate and cooperate. We provide recommendations to the two governments and the global health community to control the ongoing COVID-19 pandemic and prepare for future threats. TRANSLATION: For the Chinese translation of the abstract see Supplementary Materials section.

Indexed as

HealthMedicineChinaGlobal HealthGovernment AgenciesHistory, 20th CenturyHistory, 21st CenturyHumansInternational CooperationPrivate SectorPublic HealthPublic SectorScienceUnited StatesUniversities

Identifiers

PMID33838723
PMCPMC8032253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.